These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 31933852

  • 1. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
    Li Z, Tang X, Duan S.
    Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis.
    Fan MJ, Zou YH, He PJ, Zhang S, Sun XM, Li CZ.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31092700
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
    Jin J, Chu Z, Ma P, Meng Y, Yang Y.
    Tumour Biol; 2017 Jul 28; 39(7):1010428317716250. PubMed ID: 28720069
    [Abstract] [Full Text] [Related]

  • 4. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer.
    Cao S, Lin L, Xia X, Wu H.
    Mol Ther Nucleic Acids; 2019 Sep 06; 17():455-464. PubMed ID: 31330497
    [Abstract] [Full Text] [Related]

  • 5. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D, Li Y, Luo G, Xiao X, Tao D, Wu X, Wang M, Huang C, Wang L, Zeng F, Jiang G.
    Cancer Lett; 2017 Mar 01; 388():281-291. PubMed ID: 27998761
    [Abstract] [Full Text] [Related]

  • 6. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J, Chen Y, Wang Q, Xu H, Jiang Q, Wang M, Li S, Chen Y, Wu C, Yu P, Xiao Z, Chen W, Lan Q.
    Cancer Med; 2023 Mar 01; 12(6):7309-7326. PubMed ID: 36479622
    [Abstract] [Full Text] [Related]

  • 7. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y, Yao Y, Jiang X, Zhong X, Wang Z, Li C, Kang P, Leng K, Ji D, Li Z, Huang L, Qin W, Cui Y.
    J Exp Clin Cancer Res; 2018 Apr 11; 37(1):81. PubMed ID: 29642935
    [Abstract] [Full Text] [Related]

  • 8. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X, Zhang X, Wang X, Chen L, Jiang L, Zheng A, Zhang M, Zhao L, Wei M.
    J Cell Mol Med; 2020 Jan 11; 24(1):772-784. PubMed ID: 31736268
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 11; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 10. A Review on the Role of SPRY4-IT1 in the Carcinogenesis.
    Ghafouri-Fard S, Khoshbakht T, Taheri M, Shojaei S.
    Front Oncol; 2021 Jan 11; 11():779483. PubMed ID: 35096580
    [Abstract] [Full Text] [Related]

  • 11. LncRNA SPRY4‑IT1 is upregulated and promotes the proliferation of prostate cancer cells under hypoxia in vitro.
    Sang W, Zhu R, Liu D, Gong M.
    Oncol Lett; 2023 Apr 11; 25(4):138. PubMed ID: 36909367
    [Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA SPRY4-IT1 acts as a miR-101-5p sponge to promote gastrointestinal stromal tumor progression by inhibiting ZEB1.
    Huang C, Wang M, Zhao WY, Shen YY, Zhuang C, Ni B, Yang LX, Lu L, Li XQ, Tu L, Cao H.
    Am J Transl Res; 2023 Apr 11; 15(2):1026-1040. PubMed ID: 36915750
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
    Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F.
    Oncotarget; 2017 Jan 10; 8(2):3104-3110. PubMed ID: 27902971
    [Abstract] [Full Text] [Related]

  • 14. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
    Li J, Chen Y, Chen Z, He A, Xie H, Zhang Q, Cai Z, Liu Y, Huang W.
    Tumour Biol; 2017 Jun 10; 39(6):1010428317711406. PubMed ID: 28651500
    [Abstract] [Full Text] [Related]

  • 15. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
    Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, Perera RJ.
    Cancer Res; 2011 Jun 01; 71(11):3852-62. PubMed ID: 21558391
    [Abstract] [Full Text] [Related]

  • 16. The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells.
    Mazar J, Zhao W, Khalil AM, Lee B, Shelley J, Govindarajan SS, Yamamoto F, Ratnam M, Aftab MN, Collins S, Finck BN, Han X, Mattick JS, Dinger ME, Perera RJ.
    Oncotarget; 2014 Oct 15; 5(19):8959-69. PubMed ID: 25344859
    [Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.
    Shen F, Cai WS, Feng Z, Chen JW, Feng JH, Liu QC, Fang YP, Li KP, Xiao HQ, Cao J, Xu B.
    Oncotarget; 2017 Feb 28; 8(9):14479-14486. PubMed ID: 27391336
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY, Li RK, Qi Y, Li XN, Yang Y, Liu DL, Zhao J, Zhu DY, Wu K, Zhou XD, Zhao S.
    Cell Biol Toxicol; 2016 Oct 28; 32(5):391-401. PubMed ID: 27250657
    [Abstract] [Full Text] [Related]

  • 19. Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition.
    Cui F, Wu D, He X, Wang W, Xi J, Wang M.
    Tumour Biol; 2016 Aug 28; 37(8):10871-6. PubMed ID: 26883252
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H, Liu C, Lu Z, Chen L, Wang J, Li Y, Ma H.
    Biomed Pharmacother; 2017 Apr 28; 88():529-534. PubMed ID: 28129625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.